2025-07-22 - Analysis Report
Okay, here's an analysis of TG Therapeutics Inc. (TGTX) based on the provided data, presented in a structured format with initial numerical summaries followed by a concise analysis:

**Report on TG Therapeutics Inc. (TGTX)**

**1. Performance vs. S&P 500 (VOO)**

*   **Ticker:** TGTX
*   **Company Description:** TG Therapeutics Inc is a biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases.

*   **TGTX Cumulative Return:** 66.19%
*   **VOO Cumulative Return:** 97.07%
*   **Absolute Divergence (TGTX - VOO):** -28.3%
*   **Divergence Range:** Max: 401.1, Min: -110.5
*   **Relative Divergence:** 16.1

**Analysis:** TGTX has underperformed the S&P 500 (VOO) over the analyzed period. The relative divergence of 16.1 suggests that TGTX's current divergence is near the lower end of its historical divergence range compared to VOO.

**Alpha, Beta Analysis**

| Year       | CAGR    | MDD    | Alpha    | Beta   | Cap(B) |
| :----------- | :------ | :----- | :------- | :----- | :------ |
| 2015-2017  | -6.0%   | 56.5%  | -35.0%   | -0.1   | 1.3     |
| 2016-2018  | -8.0%   | 58.6%  | -26.0%   | 0.0    | 0.7     |
| 2017-2019  | 74.0%   | 58.6%  | 44.0%    | 0.0    | 1.8     |
| 2018-2020  | 402.0%  | 58.6%  | 382.0%   | -0.4   | 8.3     |
| 2019-2021  | 125.0%  | 63.5%  | 76.0%    | -0.5   | 3.0     |
| 2020-2022  | -76.0%  | 70.4%  | -78.0%   | -0.6   | 1.9     |
| 2021-2023  | -350.0% | 70.4%  | -368.0%  | -0.8   | 2.7     |
| 2022-2024  | 71.0%   | 73.1%  | 45.0%    | -0.9   | 4.8     |
| 2023-2025  | 73.0%   | 73.1%  | 24.0%    | 0.4    | 5.9     |

**Analysis:**
*   **CAGR:**  Shows highly variable growth (both positive and negative).
*   **MDD:** High Maximum Drawdown suggests significant price volatility.
*   **Alpha:**  The Alpha is largely negative, suggesting underperformance relative to its benchmark. However, there are periods of positive Alpha, indicating periods of outperformance.
*   **Beta:**  The Beta is relatively low, suggesting the stock is less sensitive to market movements.  Some periods have a negative beta, indicating that the stock may move in the opposite direction of the market during those times.
*   **Cap(B):**  The Market Cap has fluctuated, suggesting changes in investor sentiment and/or company performance over these periods.

**2. Recent Stock Price Movement**

*   **Current Price:** 37.42
*   **Previous Close:** 37.91
*   **Price Change:** -1.29%
*   **5-Day Moving Average:** 38.26
*   **20-Day Moving Average:** 37.25
*   **60-Day Moving Average:** 37.12

**Analysis:** The stock price has slightly decreased recently. The price is below the 5-day moving average but above the 20-day and 60-day moving averages, suggesting a potential short-term downward trend but a stable longer-term trend. The minor negative change from the previous close (-1.29%) doesn't indicate a major volatility event.

**3. Risk Indicators and Expected Return**

*   **Market Risk Indicator (MRI):** 0.3383 (Low Risk)
*   **RSI:** 55.98
*   **PPO:** 0.31
*   **Hybrid Signal:** cash_0%_Buy 90% of cash (5 shares - Safe - MRI:0.33)
*   **20-Day Relative Divergence Change:** +0.5 (Short-term increase)
*   **Expected Return:** -242.0%

**Analysis:**

*   The MRI suggests a low-risk environment.
*   The RSI is slightly above 50, indicating neutral to slightly bullish momentum.
*   The PPO is positive, indicating the short-term moving average is above the long-term moving average, a bullish signal.
*   The positive change in relative divergence indicates a short-term upward trend compared to the S&P 500.
*   However, the very negative expected return (-242.0%) suggests a significant potential underperformance relative to the S&P 500 over a long-term investment horizon.
*   The Hybrid Signal suggests a "Buy" recommendation with a conservative cash allocation.

**4. Recent News & Significant Events**

*   **2025-07-20:** Major business developments, regulatory changes, or market events.
*   **2025-07-19:** Analyst discussions regarding recent performance, industry trends, and global economic factors.
*   **2025-07-22:** Notable stock volatility due to recent news, earnings reports, or executive actions.
*   **2025-07-21:** Market experts highlighting both risks and opportunities.

**Analysis:** Recent news indicates potential volatility and significant developments influencing the stock. Investors should monitor news and company announcements closely.

**5. Recent Earnings Analysis**

| 날짜       | EPS     | 매출      |
| :--------- | :------ | :-------- |
| 2025-05-09 | 0.03    | 0.12 B$   |
| 2024-11-07 | 0.03    | 0.08 B$   |
| 2024-08-09 | 0.05    | 0.07 B$   |
| 2024-05-06 | -0.07   | 0.06 B$   |
| 2025-05-09 | -0.07   | 0.06 B$   |

**Analysis:** Earnings per share (EPS) has fluctuated, showing a mix of profitability and losses. Revenue has generally increased over the past few quarters, suggesting potential growth.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue | Profit Margin |
| :----------- | :------ | :------------ |
| 2025-03-31 | $0.12B  | 87.14%        |
| 2024-12-31 | $0.11B  | 85.77%        |
| 2024-09-30 | $0.08B  | 88.86%        |
| 2024-06-30 | $0.07B  | 88.70%        |
| 2024-03-31 | $0.06B  | 91.43%        |

**Capital and Profitability:**

| Quarter      | Equity | ROE      |
| :----------- | :------ | :------- |
| 2025-03-31 | $0.24B  | 2.13%    |
| 2024-12-31 | $0.22B  | 10.49%   |
| 2024-09-30 | $0.19B  | 2.02%    |
| 2024-06-30 | $0.18B  | 3.87%    |
| 2024-03-31 | $0.16B  | -6.69%   |

**Analysis:**
*   **Revenue and Profitability:** Revenue has been increasing steadily. Profit margins are very high, indicating efficient cost management.
*   **Capital and Profitability:** Equity has been increasing, suggesting financial health. ROE (Return on Equity) has fluctuated, with some quarters showing strong returns and others showing weaker or negative returns.

**7. Overall Summary**

TGTX has underperformed the S&P 500. Recent news suggests potential volatility and significant events, which can effect stock performance. Revenue has been on the rise, and profit margins are very high, which are positive signs. However, the negative expected return is concerning. Overall, TGTX presents a mixed picture, with potential growth opportunities balanced by significant risk and volatility. Further monitoring of company news and announcements is crucial for investors.
